Vaccine self-sufficiency by year-end, says Randeep Guleria
The Hindu
‘Third wave of COVID-19 could be milder with fewer deaths’
By the end of the year, India will be self-sufficient in terms of vaccines. Already, local manufacturers such as Serum Institute of India that makes Covishield and Bharat Biotech that manufactures Covaxin, have scaled up their production, Director of AIIMS Randeep Guleria has said. The government has also given its nod to other manufacturers such as Zydus Cadila and Moderna, to market their vaccines. It is now up to them to study and work out how to market them and talks are also on with Pfizer and others, he has added. Mr. Guleria, who was here in connection with a programme on Saturday, told The Hindu that at least 50 crore people had received at least one vaccine dose, and by year-end at least 70% of the population was likely to be inoculated.More Related News